These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1414 related items for PubMed ID: 20207829

  • 1. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
    Cohen P, Germak J, Rogol AD, Weng W, Kappelgaard AM, Rosenfeld RG, American Norditropin Study Group.
    J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
    [Abstract] [Full Text] [Related]

  • 2. Dose-sparing and safety-enhancing effects of an IGF-I-based dosing regimen in short children treated with growth hormone in a 2-year randomized controlled trial: therapeutic and pharmacoeconomic considerations.
    Cohen P, Weng W, Rogol AD, Rosenfeld RG, Kappelgaard AM, Germak J.
    Clin Endocrinol (Oxf); 2014 Jul; 81(1):71-6. PubMed ID: 24428305
    [Abstract] [Full Text] [Related]

  • 3. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB, Traunecker R, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, Binder G.
    Horm Res; 2005 Jul; 64(2):68-76. PubMed ID: 16113581
    [Abstract] [Full Text] [Related]

  • 4. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.
    Kriström B, Aronson AS, Dahlgren J, Gustafsson J, Halldin M, Ivarsson SA, Nilsson NO, Svensson J, Tuvemo T, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 2009 Feb; 94(2):483-90. PubMed ID: 19001519
    [Abstract] [Full Text] [Related]

  • 5. Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study.
    Cohen P, Rogol AD, Howard CP, Bright GM, Kappelgaard AM, Rosenfeld RG, American Norditropin Study Group.
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2480-6. PubMed ID: 17356043
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Secondary IGF-I deficiency as a prognostic factor of growth hormone (GH) therapy effectiveness in children with isolated, non-acquired GH deficiency.
    Smyczyńska J, Stawerska R, Hilczer M, Lewiński A.
    Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):209-14. PubMed ID: 25607339
    [Abstract] [Full Text] [Related]

  • 11. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
    Soliman A, Rogol AD, Elsiddig S, Khalil A, Alaaraj N, Alyafie F, Ahmed H, Elawwa A.
    J Pediatr Endocrinol Metab; 2021 Oct 26; 34(10):1263-1271. PubMed ID: 34291621
    [Abstract] [Full Text] [Related]

  • 12. IGF-1 and growth response to adult height in a randomized GH treatment trial in short non-GH-deficient children.
    Kriström B, Lundberg E, Jonsson B, Albertsson-Wikland K, study group.
    J Clin Endocrinol Metab; 2014 Aug 26; 99(8):2917-24. PubMed ID: 24823461
    [Abstract] [Full Text] [Related]

  • 13. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A, González L, Gunczler P, Lanes R.
    J Pediatr Endocrinol Metab; 2012 Aug 26; 25(7-8):651-7. PubMed ID: 23155689
    [Abstract] [Full Text] [Related]

  • 14. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
    Wacharasindhu S, Supornsilchai V, Aroonparkmongkol S, Srivuthana S.
    J Med Assoc Thai; 2007 Oct 26; 90(10):2047-52. PubMed ID: 18041422
    [Abstract] [Full Text] [Related]

  • 15. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB, Lindberg A, Albertsson-Wikland K, Wilton P, Price DA, Reiter EO.
    J Clin Endocrinol Metab; 2005 Apr 26; 90(4):1966-71. PubMed ID: 15634724
    [Abstract] [Full Text] [Related]

  • 16. Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age.
    Bannink EM, van Doorn J, Mulder PG, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2007 Aug 26; 92(8):2992-3000. PubMed ID: 17504895
    [Abstract] [Full Text] [Related]

  • 17. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ, Boonstra VH, Mulder PG, Odink RJ, Stokvis-Brantsma WH, Rongen-Westerlaken C, Mulder JC, Delemarre-Van de Waal H, Reeser HM, Jansen M, Waelkens JJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2003 Dec 26; 59(6):779-87. PubMed ID: 14974922
    [Abstract] [Full Text] [Related]

  • 18. Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency.
    Albertsson-Wikland K, Aronson AS, Gustafsson J, Hagenäs L, Ivarsson SA, Jonsson B, Kriström B, Marcus C, Nilsson KO, Ritzén EM, Tuvemo T, Westphal O, Aman J.
    J Clin Endocrinol Metab; 2008 Nov 26; 93(11):4342-50. PubMed ID: 18728172
    [Abstract] [Full Text] [Related]

  • 19. Do growth hormone (GH) serial sampling, insulin-like growth factor-I (IGF-I) or auxological measurements have an advantage over GH stimulation testing in predicting the linear growth response to GH therapy?
    Rogol AD, Blethen SL, Sy JP, Veldhuis JD.
    Clin Endocrinol (Oxf); 2003 Feb 26; 58(2):229-37. PubMed ID: 12580940
    [Abstract] [Full Text] [Related]

  • 20. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
    Smith WJ, Nam TJ, Underwood LE, Busby WH, Celnicker A, Clemmons DR.
    J Clin Endocrinol Metab; 1993 Nov 26; 77(5):1294-9. PubMed ID: 7521346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 71.